Stocktoria
INSULET CORP PODD
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2007-05-15
INSULET CORP financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $2.7B | $2.1B | $1.7B | $1.3B | $1.1B |
| Gross profit | $1.9B | $1.4B | $1.2B | $805.6M | $752.1M |
| R&D expense | $301.1M | $219.6M | $205.0M | $180.2M | $160.1M |
| SG&A expense | $1.2B | $917.2M | $734.8M | $587.8M | $466.0M |
| Operating income | $473.8M | $308.9M | $220.1M | $37.6M | $126.0M |
| Interest expense | — | — | $36.2M | $36.0M | $61.7M |
| Income tax | $92.4M | -$118.1M | $8.3M | $5.2M | $3.7M |
| Net income | $247.1M | $418.3M | $206.3M | $4.6M | $16.8M |
| EPS (diluted) | $3.48 | $5.78 | $2.94 | $0.07 | $0.24 |
| Operating cash flow | $569.3M | $430.2M | $145.7M | $119.0M | -$68.1M |
| Free cash flow | $377.7M | $305.3M | $70.1M | -$3.9M | -$180.0M |
| Inventory | $452.6M | $430.4M | $402.6M | $346.8M | $303.2M |
| Total assets | $3.2B | $3.1B | $2.6B | $2.3B | $2.0B |
| Total liabilities | $1.7B | $1.9B | $1.9B | $1.8B | $1.5B |
| Shareholders' equity | $1.5B | $1.2B | $732.7M | $476.4M | $556.3M |
Source: SEC EDGAR filings · CIK 0001145197 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.